Search
                    Chronic Heart Failure Clinical Trials
A listing of 5  Chronic Heart Failure  clinical trials  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 5 of 5
        
        
    
                There are currently 5 active clinical trials seeking participants for Chronic Heart Failure research studies. The states with the highest number of trials for Chronic Heart Failure participants are California, Florida, Texas and Tokyo.
            
                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Dilated Cardiomyopathy (DCM) Research Study
            
        Recruiting
            
        If you are identified as eligible for investigational genetic testing, you will be sent a saliva collection kit to your home. Once you have completed and returned your kit to Sano Genetics, your sample will be tested for a specific genetic pathway called BAG3.
Investigational genetic testing can help you better understand your body and its needs, as well as how DCM may be passed down in your family. Those who are identified as having a variant in the BAG3 gene will be referred to an upcoming clinical trial.
    Investigational genetic testing can help you better understand your body and its needs, as well as how DCM may be passed down in your family. Those who are identified as having a variant in the BAG3 gene will be referred to an upcoming clinical trial.
                            Conditions: 
                                    
        
            
                        Dilated Cardiomyopathy (DCM)
                    
                                    
                        Cardiovascular Diseases
                    
                                    
                        Cardiomyopathy
                    
                                    
                        Cardiovascular Disease
                    
                                    
                        Heart Failure
                    
                                    Featured Trial
                
                Heart failure clinical study is now enrolling
            
        Recruiting
            
        Are you interested in a clinical study exploring an investigational medicine for heart failure, also known as HF? The MARITIME-HF clinical study is testing an investigational medicine to see if it can reduce HF-related symptoms and risk of hospitalization in people living with HF and obesity.
Researchers are focused on developing a potential option for reducing HF-related symptoms. By participating, you may contribute to research that may offer benefits for those in the future in need of a different way to manage their HF.
Answer just a few questions to submit your information and see if you may qualify
    Researchers are focused on developing a potential option for reducing HF-related symptoms. By participating, you may contribute to research that may offer benefits for those in the future in need of a different way to manage their HF.
Answer just a few questions to submit your information and see if you may qualify
                            Conditions: 
                                    
        
            
                        Heart Failure
                    
                                    
                        Congestive Heart Failure
                    
                                    
                        Chronic Heart Failure
                    
                                    
                        Heart Failure
                    
                                    
                        Congestive
                    
                                    
                
                                    Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
                                
            
            
        Recruiting
                            
            
                The goal of this clinical trial is to learn if the IV Iron treatment ferric derisomaltose helps in the treatment of chronic heart failure in people with iron deficiency. The main question it aims to answer is:
• How many participants are admitted to the hospital or die from a disease in the heart or blood vessels
Researchers will compare treatment with ferric derisomaltose to no treatment with ferric derisomaltose. This will be done to see how well ferric derisomaltose works.
Participants wil...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                07/17/2025
            
            Locations: Private clinic, Pasadena, California         
        
        
            Conditions: Chronic Heart Failure, Iron Deficiencies
        
            
        
    
                
                                    Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
                                
            
            
        Recruiting
                            
            
                The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF. Participants will be randomized (1:1 ratio) to receive either the Mindful Steps intervention or usual care for 12 months, with bo...  Read More             
        
        
    Gender:
                ALL
            Ages:
                40 years and above
            Trial Updated:
                05/22/2025
            
            Locations: VA Boston, Boston, Massachusetts  +1 locations         
        
        
            Conditions: Chronic Obstructive Pulmonary Disease, Chronic Heart Failure
        
            
        
    
                
                                    Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction
                                
            
            
        Recruiting
                            
            
                This study will evaluate the efficacy, safety, tolerability and pharmacokinetics of JTT-861 administered once daily for 12 weeks in subjects with heart failure with reduced ejection fraction (HFrEF) who are on a stable, guideline-directed medical therapy for heart failure.             
        
        
    Gender:
                ALL
            Ages:
                Between 30 years and 85 years
            Trial Updated:
                04/18/2025
            
            Locations: Nature Coast Clinical Research, Crystal River, Florida  +52 locations         
        
        
            Conditions: Chronic Heart Failure
        
            
        
    
                
                                    Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
                                
            
            
        Recruiting
                            
            
                The objective of this prospective, multicenter controlled study is to assess the feasibility of a patient-tailored implantation by creating a cloud-based pre-procedural multimodality CRT-roadmap by integration of 3D images from 3D activation sequence from ECG, and coronary venous anatomy from cardiac computed tomography. This CRT-roadmap will be used to guide LV lead placement to a coronary vein in an electrically late-activated region.
Study Hypothesis: At least 75% of patients undergoing a CR...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                10/22/2024
            
            Locations: Rush University Medical center, Chicago, Illinois  +12 locations         
        
        
            Conditions: Cardiac Resynchronization Therapy, Chronic Heart Failure, Left Bundle-Branch Block
        
            
        
    
                
                                    Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
                                
            
            
        Recruiting
                            
            
                The REFORM-HF study aims to test a new technology, AquaPass, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure.
Patients will wear a lightweight suit that helps remove excess fluids through their sweat.
The investigators want to see if the AquaPass system can remove an additional 500mL of fluids during treatment, alongside patients' regular medications like diuretics.
Participants will select if to be treated at their home or in the outpatient clinic.             
        
        
    Gender:
                ALL
            Ages:
                Between 21 years and 80 years
            Trial Updated:
                09/17/2024
            
            Locations: Rochester Regional Health, Rochester, New York  +3 locations         
        
        
            Conditions: Chronic Heart Failure, CKD Stage 3
        
            
        
    1 - 5 of 5
            
            
        